We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use 51²è¹Ý, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Easy read of the final findings and recommendations of the review into the operational effectiveness of the Care Quality Commission.
Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.
Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in human samples in England.
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.
Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).
Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection (CDI) reported by independent sector healthcare organisations, with accompanying commentary. Official statistics …
Voluntary surveillance of streptococcal bacteraemia in England.
Notifications of scarlet fever disease in England and data from invasive group A streptococci (iGAS) surveillance.
Annual report and data tables showing frequency of bloodstream infections in critical care units in England, the microbes that cause them, and linked factors.
Voluntary surveillance of paediatric bacteraemia in England.
This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres.
The ESPAUR report includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation, and awareness activities.
Annual reports on voluntary surveillance of fungaemia (blood infections due to yeast species) in England.
Trends in ribotypes of Clostridioides difficile (C. difficile) and research into the increased frequency of C. difficile infections (CDI).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve 51²è¹Ý, we’d like to know more about your visit today. .